325 results on '"Csabai, I."'
Search Results
102. Improving signal peptide prediction accuracy by simulated neural network
- Author
-
Ladunga, I., primary, Czakó, F., additional, Csabai, I., additional, and Geszti, T., additional
- Published
- 1991
- Full Text
- View/download PDF
103. The Low-Resolution Spectrograph of the Hobby-Eberly Telescope. II. Observations of Quasar Candidates from the Sloan Digital Sky SurveyBased on observations obtained with the Sloan Digital Sky Survey, which is owned and operated by the Astrophysical Research Consortium.Based on observations obtained with the Hobby-Eberly Telescope, which is a joint project of the University of Texas at Austin, the Pennsylvania State University, Stanford University, Ludwig-Maximillians-Universität München, and Georg-August-Universität Göttingen.
- Author
-
Schneider, D. P., Hill, Gary J., Fan, X., Ramsey, L. W., MacQueen, P. J., Weedman, D. W., Booth, J. A., Eracleous, M., Gunn, J. E., Lupton, R. H., Adams, M. T., Bastian, S., Bender, R., Berman, E., Brinkmann, J., Csabai, I., Federwitz, G., Gurbani, V., Hennessy, G. S., Hill, G. M., Hindsley, R. B., Ivezic, Z., Knapp, G. R., Lamb, D. Q., Lindenmeyer, C., Mantsch, P., Nance, C., Nash, T., Pier, J. R., Rechenmacher, R., Rhoads, B., Rivetta, C. H., Robinson, E. L., Roman, B., Sergey, G., Shetrone, M., Stoughton, C., Strauss, M. A., Szokoly, G. P., Tucker, D. L., Wesley, G., Willick, J., Worthington, P., and York, D. G.
- Abstract
This paper describes spectra of quasar candidates acquired during the commissioning phase of the Low-Resolution Spectrograph of the Hobby-Eberly Telescope. The objects were identified as possible quasars from multicolor image data from the Sloan Digital Sky Survey. The 10 sources had typical r'magnitudes of 19-20, except for one extremely red object with r'? 23. The data, obtained with exposure times between 10 and 25 minutes, reveal that the spectra of four candidates are essentially featureless and are not quasars, five are quasars with redshifts between 2.92 and 4.15 (including one broad absorption line quasar), and the red source is a very late M star or early L dwarf.
- Published
- 2000
- Full Text
- View/download PDF
104. Spatial indexing of large multidimensional databases
- Author
-
Csabai, I., Trencseni, M., Herczegh, G., László Dobos, Jozsa, P., Purger, N., Budavari, T., and Szalay, A.
- Subjects
FOS: Computer and information sciences ,Computer Science - Databases ,Databases (cs.DB) ,Computer Science::Databases - Abstract
Scientific endeavors such as large astronomical surveys generate databases on the terabyte scale. These, usually multidimensional databases must be visualized and mined in order to find interesting objects or to extract meaningful and qualitatively new relationships. Many statistical algorithms required for these tasks run reasonably fast when operating on small sets of in-memory data, but take noticeable performance hits when operating on large databases that do not fit into memory. We utilize new software technologies to develop and evaluate fast multidimensional indexing schemes that inherently follow the underlying, highly non-uniform distribution of the data: they are layered uniform grid indices, hierarchical binary space partitioning, and sampled flat Voronoi tessellation of the data. Our working database is the 5-dimensional magnitude space of the Sloan Digital Sky Survey with more than 270 million data points, where we show that these techniques can dramatically speed up data mining operations such as finding similar objects by example, classifying objects or comparing extensive simulation sets with observations. We are also developing tools to interact with the multidimensional database and visualize the data at multiple resolutions in an adaptive manner., 12 pages, 16 figures; CIDR 2007
105. Redshifts of the long gamma-ray bursts
- Author
-
Zsolt Bagoly, Csabai, I., Meszaros, A., Meszaros, P., Horvath, I., Balazs, Lg, and Vavrek, R.
- Subjects
Astrophysics::High Energy Astrophysical Phenomena ,Astrophysics (astro-ph) ,FOS: Physical sciences ,Astrophysics::Cosmology and Extragalactic Astrophysics ,Astrophysics ,Astrophysics::Galaxy Astrophysics - Abstract
The low energy spectra of some gamma-ray bursts' show excess components beside the power-law dependence. The consequences of such a feature allows to estimate the gamma photometric redshift of the long gamma-ray bursts in the BATSE Catalog. There is good correlation between the measured optical and the estimated gamma photometric redshifts. The estimated redshift values for the long bright gamma-ray bursts are up to z=4, while for the the faint long bursts - which should be up to z=20 - the redshifts cannot be determined unambiguously with this method. The redshift distribution of all the gamma-ray bursts with known optical redshift agrees quite well with the BATSE based gamma photometric redshift distribution., Comment: published in Baltic Astronomy
106. The European traffic observatory measurement infrastructure (ETOMIC)
- Author
-
Magana, E., primary, Morato, D., additional, Izal, M., additional, Aracil, J., additional, Naranjo, F., additional, Astiz, F., additional, Alonso, U., additional, Csabai, I., additional, Haga, P., additional, Simon, G., additional, Steger, J., additional, and Vattay, G., additional
- Full Text
- View/download PDF
107. The European Traffic Observatory Measurement Infraestructure (ETOMIC): A Testbed for Universal Active and Passive Measurements
- Author
-
Morato, D., primary, Magana, E., additional, Izal, M., additional, Aracil, J., additional, Naranjo, F., additional, Astiz, F., additional, Alonso, U., additional, Csabai, I., additional, Haga, P., additional, Simon, G., additional, Steger, J., additional, and Vattay, G., additional
- Full Text
- View/download PDF
108. Learning vector quantization without and with habituation
- Author
-
Geszti, T., primary and Csabai, I., additional
- Full Text
- View/download PDF
109. Are strong z 0.5 MgII absorbers the signature of super-winds?
- Author
-
Bouché, N., Murphy, M., Péroux, C., Csabai, I., and Wild, V.
- Abstract
BACKGROUND: In the process of galaxy formation, super-nova driven feedback from low-mass galaxies is the process that most readily account for the galaxy mass-metallicity relation and for the shallower galaxy luminosity function (LF) compared to the halo mass function. Absorption-selected galaxies are prime candidates for the sites of starburst activity as (1) they probe the gaseous halos of galaxies up to ~50 kpc (Steidel 1995), and (2) galaxies on the faint end of the LF are likely dominating the statistics. Galaxies selected via their MgII λ2796/2803 doublet absorption against background QSOs are especially well suited as Mg is produced by type II supernova.GOAL: Our project was to constrain the physical models of the gaseous halos by measuring the dark matter halo-mass (Mh) of the MgII host-galaxies statistically, i.e. without identifying spectroscopically the host-galaxy.METHOD: We have used the cross-correlation w(rθ) (over co-moving scales rθ:0.05–13h−1Mpc) between our sample of 1800 z 0.5 MgII absorbers with equivalent w width W2796r−0.3 Å, and 250,000 Luminous Red Galaxies (LRGs), both selected from SDSS/DR3. The cross-correlation relies on the LRG photometric redshifts, but is not affected from contaminants such as stars or foreground and background galaxies as shown theoretically in Bouché et al. 2005 and empirically in Bouché et al. 2006.RESULTS: From the cross-correlation analysis, we found (Bouché et al. 2006) (i) that the absorber host-halo mean mass is log Mh (M) = 11.94 ±0.31(stat)+0.24−0.25(sys), i.e. about 1/2 L*, and (ii) an anti-correlation between halo mass Mh and equivalent width W2796r.INTERPRETATION: One SDSS MgII absorber (system) is made of several sub-components or clouds and the stronger the equivalent with of the absorber, the more clouds per system spread over a larger velocity range (Δv). This follows since each sub-component has a velocity width of ~ 5 kms s−1 (Churchill 1997). As result, the equivalent width W2796r is a measure of velocity width (Δv) as demonstrated by Ellison 2006. Together with our SDSS results, these relations imply a mass–velocity Mh–Δv anti-correlation. If the clouds in the host-halos were virialized, velocity and mass would have been correlated.CONCLUSION: Therefore, our Mh–Δv anti-correlation shows that the clouds are not virialized in the gaseous halos of the hosts. This conclusion is best understood in the context of starburst driven outflows where the velocity Δv is related to bulk motion. This opens the possibility to study M82-analogs up to z ~ 2.0 using the MgII selection. [ABSTRACT FROM PUBLISHER]
- Published
- 2006
- Full Text
- View/download PDF
110. Learning vector quantization without and with habituation.
- Author
-
Geszti, T. and Csabai, I.
- Published
- 1992
- Full Text
- View/download PDF
111. Periodic orbit theory applied to a chaotically oscillating gas bubble in water.
- Author
-
Simon, G., Cvitanovic, P., Levinsen, M. T., Csabai, I., and Horváth, Á
- Published
- 2002
- Full Text
- View/download PDF
112. Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage
- Author
-
Fathia Mami-Chouaib, Vincent Cattoir, Guido Kroemer, Mohamed Sassi, Krisztián Papp, Nathalie Labarrière, Valerio Iebba, Valentin Quiniou, Romain Boidot, Zsofia Sztupinszki, Nicola Segata, Ivo G. Boneca, Friedemann Loos, Sylvain Simon, Jacques Bou-Khalil, Richard J. Wheeler, Carlos López-Otín, Andréanne Gagné, Luisa De Sordi, Barbara S. Sixt, Philippe Joubert, Clara-Maria Scarlata, Fabien Lemaitre, Peng Liu, Laurent Debarbieux, Alexander M.M. Eggermont, Paola Nisticò, Didier Raoult, David Klatzmann, Connie P.M. Duong, Belinda Palermo, Lisa Derosa, Maha Ayyoub, Maryam Tidjani Alou, Meriem Messaoudene, B. Escudier, François Ghiringhelli, Aurélie Fluckiger, Gladys Ferrere, Saber Khelaifia, Bertrand Routy, Laurence Albiges, Edoardo Pasolli, Anne Gaëlle Goubet, Zoltan Szallasi, Romain Daillère, István Csabai, Laurence Zitvogel, Fabrice Andre, Francesco Facciolo, Corentin Richard, Catherine Rabu, Institut Gustave Roussy (IGR), Immunologie anti-tumorale et immunothérapie des cancers (ITIC), Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, ARN régulateurs bactériens et médecine (BRM), Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Umeå University, Centre de Recherche des Cordeliers (CRC (UMR_S_1138 / U1138)), École Pratique des Hautes Études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université Paris Cité (UPCité), Centre d'oncologie et de radiothérapie du parc [Dijon], Institut de médecine génomique et d’immunothérapie (Genomic and Immunotherapy Medical Institute) (institut GIMI), Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)-Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon)-Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), UNICANCER-UNICANCER-Etablissement français du sang [Bourgogne-Franche-Comté] (EFS BFC)-FHU TRANSLAD (CHU de Dijon), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Anti-Tumor Immunosurveillance and Immunotherapy (CRCINA-ÉQUIPE 3), Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes), Microbes évolution phylogénie et infections (MEPHI), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Université Paris-Saclay, Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), Université Laval [Québec] (ULaval), Institut Pasteur [Paris] (IP), Centre de Recherche Saint-Antoine (CRSA), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Centre de Recherches en Cancérologie de Toulouse (CRCT), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), National Cancer Institute Regina Elena [Rome, Italy], Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), UNICANCER, Boston Children's Hospital, Harvard Medical School [Boston] (HMS), Eötvös Loránd University (ELTE), University of Trento [Trento], Universidad de Oviedo [Oviedo], Centre d'investigation clinique Biothérapie [CHU Pitié-Salpêtrière] (CIC-BTi), Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Immunologie intégrative des tumeurs et immunothérapie des cancers (INTIM), Centre Hospitalier de l'Université de Montréal (CHUM), Université de Montréal (UdeM), Centre National de Référence de la Résistance aux Antibiotiques [CHU Rennes] (CNR), CHU Pontchaillou [Rennes], Institut Universitaire de France (IUF), Ministère de l'Education nationale, de l’Enseignement supérieur et de la Recherche (M.E.N.E.S.R.), ANR-16-RHUS-0008,LUMIERE,LUMIERE(2016), ANR-19-CE15-0029,Ileobiome,Régulation des réponses immunitaires iléales dans l'immunosurveillance du cancer du colon: rôle du microbiote et des antigènes des cellules souches.(2019), Bernardo, Elizabeth, École pratique des hautes études (EPHE), UNICANCER-UNICANCER-Etablissement français du sang [Bourgogne-Franche-Comté] (EFS [Bourgogne-Franche-Comté])-FHU TRANSLAD (CHU de Dijon), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre d'investigation clinique pluridisciplinaire [CHU Pitié Salpêtrière] (CIC-P 1421), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université de Paris (UP), Genetic and Immunology Medical Institute (GIMI), UNICANCER-UNICANCER-Etablissement français du sang [Bourgogne-Franche-Comté] (EFS [Bourgogne-Franche-Comté]), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA), Institut Pasteur [Paris], Centre de Recherche Saint-Antoine (CR Saint-Antoine), Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Saint-Antoine [AP-HP], Centre d’Investigation Clinique intégré en Biothérapies et immunologie [AP-HP pitié-salpêtrière, Paris] (CIC-BTi), CHU Pitié-Salpêtrière [AP-HP], Fluckiger, A., Daillere, R., Sassi, M., Sixt, B. S., Liu, P., Loos, F., Richard, C., Rabu, C., Alou, M. T., Goubet, A. -G., Lemaitre, F., Ferrere, G., Derosa, L., Duong, C. P. M., Messaoudene, M., Gagne, A., Joubert, P., De Sordi, L., Debarbieux, L., Simon, S., Scarlata, C. -M., Ayyoub, M., Palermo, B., Facciolo, F., Boidot, R., Wheeler, R., Boneca, I. G., Sztupinszki, Z., Papp, K., Csabai, I., Pasolli, E., Segata, N., Lopez-Otin, C., Szallasi, Z., Andre, F., Iebba, V., Quiniou, V., Klatzmann, D., Boukhalil, J., Khelaifia, S., Raoult, D., Albiges, L., Escudier, B., Eggermont, A., Mami-Chouaib, F., Nistico, P., Ghiringhelli, F., Routy, B., Labarriere, N., Cattoir, V., Kroemer, G., Zitvogel, L., and de Sordi, L.
- Subjects
H-2 Antigen ,Programmed Cell Death 1 Receptor ,CD8-Positive T-Lymphocytes ,Epitope ,Epitopes ,Feces ,Mice ,0302 clinical medicine ,Enterococcus hirae ,Neoplasms ,Monoclonal ,Bacteriophages ,0303 health sciences ,Multidisciplinary ,biology ,Antibodies, Monoclonal ,Viral Tail Proteins ,Alkylating ,3. Good health ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Cross Reaction ,Immunotherapy ,Human ,T cell ,Antineoplastic Agents ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,Cross Reactions ,Major histocompatibility complex ,Antibodies ,Microbiology ,03 medical and health sciences ,Animals ,Antigens, Neoplasm ,Antineoplastic Agents, Alkylating ,Cyclophosphamide ,Gastrointestinal Microbiome ,H-2 Antigens ,Histocompatibility Antigens Class I ,Humans ,[SDV.CAN] Life Sciences [q-bio]/Cancer ,Antigen ,MHC class I ,medicine ,Antigens ,Bacteriophage ,Prophage ,030304 developmental biology ,Animal ,CD8-Positive T-Lymphocyte ,biology.organism_classification ,biology.protein ,Neoplasm ,Fece ,CD8 - Abstract
International audience; Intestinal microbiota have been proposed to induce commensal-specific memory T cells that cross-react with tumor-associated antigens. We identified major histocompatibility complex (MHC) class I-binding epitopes in the tail length tape measure protein (TMP) of a prophage found in the genome of the bacteriophage Enterococcus hirae Mice bearing E. hirae harboring this prophage mounted a TMP-specific H-2Kb-restricted CD8+ T lymphocyte response upon immunotherapy with cyclophosphamide or anti-PD-1 antibodies. Administration of bacterial strains engineered to express the TMP epitope improved immunotherapy in mice. In renal and lung cancer patients, the presence of the enterococcal prophage in stools and expression of a TMP-cross-reactive antigen by tumors correlated with long-term benefit of PD-1 blockade therapy. In melanoma patients, T cell clones recognizing naturally processed cancer antigens that are cross-reactive with microbial peptides were detected.
- Published
- 2020
113. Author Correction: Time-series sewage metagenomics distinguishes seasonal, human-derived and environmental microbial communities potentially allowing source-attributed surveillance.
- Author
-
Becsei Á, Fuschi A, Otani S, Kant R, Weinstein I, Alba P, Stéger J, Visontai D, Brinch C, de Graaf M, Schapendonk CME, Battisti A, De Cesare A, Oliveri C, Troja F, Sironen T, Vapalahti O, Pasquali F, Bányai K, Makó M, Pollner P, Merlotti A, Koopmans M, Csabai I, Remondini D, Aarestrup FM, and Munk P
- Published
- 2024
- Full Text
- View/download PDF
114. Frequent CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression.
- Author
-
Diossy M, Tisza V, Li H, Sahgal P, Zhou J, Sztupinszki Z, Young D, Nousome D, Kuo C, Jiang J, Chen Y, Ebner R, Sesterhenn IA, Moncur JT, Chesnut GT, Petrovics G, Klus GT, Valcz G, Nuzzo PV, Ribli D, Börcsök J, Prosz A, Krzystanek M, Ried T, Szuts D, Rizwan K, Kaochar S, Pathania S, D'Andrea AD, Csabai I, Srivastava S, Freedman ML, Dobi A, Spisak S, and Szallasi Z
- Abstract
We analyzed genomic data from the prostate cancer of African- and European American men to identify differences contributing to racial disparity of outcome. We also performed FISH-based studies of Chromodomain helicase DNA-binding protein 1 (CHD1) loss on prostate cancer tissue microarrays. We created CHD1-deficient prostate cancer cell lines for genomic, drug sensitivity and functional homologous recombination (HR) activity analysis. Subclonal deletion of CHD1 was nearly three times as frequent in prostate tumors of African American than in European American men and it associates with rapid disease progression. CHD1 deletion was not associated with HR deficiency associated mutational signatures or HR deficiency as detected by RAD51 foci formation. This was consistent with the moderate increase of olaparib and talazoparib sensitivity with several CHD1 deficient cell lines showing talazoparib sensitivity in the clinically relevant concentration range. CHD1 loss may contribute to worse disease outcome in African American men., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
115. Time-series sewage metagenomics distinguishes seasonal, human-derived and environmental microbial communities potentially allowing source-attributed surveillance.
- Author
-
Becsei Á, Fuschi A, Otani S, Kant R, Weinstein I, Alba P, Stéger J, Visontai D, Brinch C, de Graaf M, Schapendonk CME, Battisti A, De Cesare A, Oliveri C, Troja F, Sironen T, Vapalahti O, Pasquali F, Bányai K, Makó M, Pollner P, Merlotti A, Koopmans M, Csabai I, Remondini D, Aarestrup FM, and Munk P
- Subjects
- Humans, Europe, Sewage microbiology, Metagenomics methods, Seasons, Microbiota genetics, Bacteria genetics, Bacteria classification, Bacteria isolation & purification, Metagenome genetics
- Abstract
Sewage metagenomics has risen to prominence in urban population surveillance of pathogens and antimicrobial resistance (AMR). Unknown species with similarity to known genomes cause database bias in reference-based metagenomics. To improve surveillance, we seek to recover sewage genomes and develop a quantification and correlation workflow for these genomes and AMR over time. We use longitudinal sewage sampling in seven treatment plants from five major European cities to explore the utility of catch-all sequencing of these population-level samples. Using metagenomic assembly methods, we recover 2332 metagenome-assembled genomes (MAGs) from prokaryotic species, 1334 of which were previously undescribed. These genomes account for ~69% of sequenced DNA and provide insight into sewage microbial dynamics. Rotterdam (Netherlands) and Copenhagen (Denmark) show strong seasonal microbial community shifts, while Bologna, Rome, (Italy) and Budapest (Hungary) have occasional blooms of Pseudomonas-dominated communities, accounting for up to ~95% of sample DNA. Seasonal shifts and blooms present challenges for effective sewage surveillance. We find that bacteria of known shared origin, like human gut microbiota, form communities, suggesting the potential for source-attributing novel species and their ARGs through network community analysis. This could significantly improve AMR tracking in urban environments., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
116. Transfer learning may explain pigeons' ability to detect cancer in histopathology.
- Author
-
Kilim O, Báskay J, Biricz A, Bedőházi Z, Pollner P, and Csabai I
- Subjects
- Animals, Machine Learning, Flight, Animal physiology, Columbidae physiology, Neoplasms pathology, Neoplasms diagnostic imaging, Neural Networks, Computer
- Abstract
Pigeons' unexpected competence in learning to categorize unseen histopathological images has remained an unexplained discovery for almost a decade (Levenson et al 2015 PLoS One 10 e0141357). Could it be that knowledge transferred from their bird's-eye views of the earth's surface gleaned during flight contributes to this ability? Employing a simulation-based verification strategy, we recapitulate this biological phenomenon with a machine-learning analog. We model pigeons' visual experience during flight with the self-supervised pre-training of a deep neural network on BirdsEyeViewNet; our large-scale aerial imagery dataset. As an analog of the differential food reinforcement performed in Levenson et al 's study 2015 PLoS One 10 e0141357), we apply transfer learning from this pre-trained model to the same Hematoxylin and Eosin (H&E) histopathology and radiology images and tasks that the pigeons were trained and tested on. The study demonstrates that pre-training neural networks with bird's-eye view data results in close agreement with pigeons' performance. These results support transfer learning as a reasonable computational model of pigeon representation learning. This is further validated with six large-scale downstream classification tasks using H&E stained whole slide image datasets representing diverse cancer types., (Creative Commons Attribution license.)
- Published
- 2024
- Full Text
- View/download PDF
117. Histopathology and proteomics are synergistic for High-Grade Serous Ovarian Cancer platinum response prediction.
- Author
-
Kilim O, Olar A, Biricz A, Madaras L, Pollner P, Szállási Z, Sztupinszki Z, and Csabai I
- Abstract
Patients with High-Grade Serous Ovarian Cancer (HGSOC) exhibit varied responses to treatment, with 20-30% showing de novo resistance to platinum-based chemotherapy. While hematoxylin-eosin (H&E) pathological slides are used for routine diagnosis of cancer type, they may also contain diagnostically useful information about treatment response. Our study demonstrates that combining H&E-stained Whole Slide Images (WSIs) with proteomic signatures using a multimodal deep learning framework significantly improves the prediction of platinum response in both discovery and validation cohorts. This method outperforms the Homologous Recombination Deficiency (HRD) score in predicting platinum response and overall patient survival. The study sets new performance benchmarks and explores the intersection of histology and proteomics, highlighting phenotypes related to treatment response pathways, including homologous recombination, DNA damage response, nucleotide synthesis, apoptosis, and ER stress. This integrative approach has the potential to improve personalized treatment and provide insights into the therapeutic vulnerabilities of HGSOC., Competing Interests: Competing Interests Z.S. is an inventor on a patent used in the myChoice HRD assay.
- Published
- 2024
- Full Text
- View/download PDF
118. Author Correction: Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting.
- Author
-
Prosz A, Sahgal P, Huffman BM, Sztupinszki Z, Morris CX, Chen D, Börcsök J, Diossy M, Tisza V, Spisak S, Likasitwatanakul P, Rusz O, Csabai I, Cecchini M, Baca Y, Elliott A, Enzinger P, Singh H, Ubellaker J, Lazaro JB, Cleary JM, Szallasi Z, and Sethi NS
- Published
- 2024
- Full Text
- View/download PDF
119. Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting.
- Author
-
Prosz A, Sahgal P, Huffman BM, Sztupinszki Z, Morris CX, Chen D, Börcsök J, Diossy M, Tisza V, Spisak S, Likasitwatanakul P, Rusz O, Csabai I, Cecchini M, Baca Y, Elliott A, Enzinger P, Singh H, Ubellaker J, Lazaro JB, Cleary JM, Szallasi Z, and Sethi NS
- Abstract
Homologous recombination (HR) and nucleotide excision repair (NER) are the two most frequently disabled DNA repair pathways in cancer. HR-deficient breast, ovarian, pancreatic and prostate cancers respond well to platinum chemotherapy and PARP inhibitors. However, the frequency of HR deficiency in gastric and esophageal adenocarcinoma (GEA) still lacks diagnostic and functional validation. Using whole exome and genome sequencing data, we found that a significant subset of GEA, but very few colorectal adenocarcinomas, show evidence of HR deficiency by mutational signature analysis (HRD score). High HRD gastric cancer cell lines demonstrated functional HR deficiency by RAD51 foci assay and increased sensitivity to platinum chemotherapy and PARP inhibitors. Of clinical relevance, analysis of three different GEA patient cohorts demonstrated that platinum treated HR deficient cancers had better outcomes. A gastric cancer cell line with strong sensitivity to cisplatin showed HR proficiency but exhibited NER deficiency by two photoproduct repair assays. Single-cell RNA-sequencing revealed that, in addition to inducing apoptosis, cisplatin treatment triggered ferroptosis in a NER-deficient gastric cancer, validated by intracellular GSH assay. Overall, our study provides preclinical evidence that a subset of GEAs harbor genomic features of HR and NER deficiency and may therefore benefit from platinum chemotherapy and PARP inhibitors., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
120. Increased frequency of CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression without inducing homologous recombination deficiency.
- Author
-
Szallasi Z, Diossy M, Tisza V, Li H, Sahgal P, Zhou J, Sztupinszki Z, Young D, Nuosome D, Kuo C, Jiang J, Chen Y, Ebner R, Sesterhenn I, Moncur J, Chesnut G, Petrovics G, T Klus G, Valcz G, Nuzzo P, Ribli D, Börcsök J, Prósz A, Krzystanek M, Ried T, Szüts D, Rizwan K, Kaochar S, Pathania S, D'Andrea A, Csabai I, Srivastava S, Freedman M, Dobi A, and Spisak S
- Abstract
We analyzed genomic data derived from the prostate cancer of African and European American men in order to identify differences that may contribute to racial disparity of outcome and that could also define novel therapeutic strategies. In addition to analyzing patient derived next generation sequencing data, we performed FISH based confirmatory studies of Chromodomain helicase DNA-binding protein 1 ( CHD1 ) loss on prostate cancer tissue microarrays. We created CRISPR edited, CHD1 deficient prostate cancer cell lines for genomic, drug sensitivity and functional homologous recombination (HR) activity analysis. We found that subclonal deletion of CHD1 is nearly three times as frequent in prostate tumors of African American men than in men of European ancestry and it associates with rapid disease progression. We further showed that CHD1 deletion is not associated with homologous recombination deficiency associated mutational signatures in prostate cancer. In prostate cancer cell line models CHD1 deletion did not induce HR deficiency as detected by RAD51 foci formation assay or mutational signatures, which was consistent with the moderate increase of olaparib sensitivity. CHD1 deficient prostate cancer cells, however, showed higher sensitivity to talazoparib. CHD1 loss may contribute to worse outcome of prostate cancer in African American men. A deeper understanding of the interaction between CHD1 loss and PARP inhibitor sensitivity will be needed to determine the optimal use of targeted agents such as talazoparib in the context of castration resistant prostate cancer.
- Published
- 2024
- Full Text
- View/download PDF
121. Mobilisation and analyses of publicly available SARS-CoV-2 data for pandemic responses.
- Author
-
Rahman N, O'Cathail C, Zyoud A, Sokolov A, Oude Munnink B, Grüning B, Cummins C, Amid C, Nieuwenhuijse DF, Visontai D, Yuan DY, Gupta D, Prasad DK, Gulyás GM, Rinck G, McKinnon J, Rajan J, Knaggs J, Skiby JE, Stéger J, Szarvas J, Gueye K, Papp K, Hoek M, Kumar M, Ventouratou MA, Bouquieaux MC, Koliba M, Mansurova M, Haseeb M, Worp N, Harrison PW, Leinonen R, Thorne R, Selvakumar S, Hunt S, Venkataraman S, Jayathilaka S, Cezard T, Maier W, Waheed Z, Iqbal Z, Aarestrup FM, Csabai I, Koopmans M, Burdett T, and Cochrane G
- Subjects
- Humans, Pandemics, Genomics, Information Dissemination, SARS-CoV-2 genetics, COVID-19 epidemiology
- Abstract
The COVID-19 pandemic has seen large-scale pathogen genomic sequencing efforts, becoming part of the toolbox for surveillance and epidemic research. This resulted in an unprecedented level of data sharing to open repositories, which has actively supported the identification of SARS-CoV-2 structure, molecular interactions, mutations and variants, and facilitated vaccine development and drug reuse studies and design. The European COVID-19 Data Platform was launched to support this data sharing, and has resulted in the deposition of several million SARS-CoV-2 raw reads. In this paper we describe (1) open data sharing, (2) tools for submission, analysis, visualisation and data claiming (e.g. ORCiD), (3) the systematic analysis of these datasets, at scale via the SARS-CoV-2 Data Hubs as well as (4) lessons learnt. This paper describes a component of the Platform, the SARS-CoV-2 Data Hubs, which enable the extension and set up of infrastructure that we intend to use more widely in the future for pathogen surveillance and pandemic preparedness.
- Published
- 2024
- Full Text
- View/download PDF
122. Annotated dataset for training deep learning models to detect astrocytes in human brain tissue.
- Author
-
Olar A, Tyler T, Hoppa P, Frank E, Csabai I, Adorjan I, and Pollner P
- Subjects
- Humans, Astrocytes metabolism, Brain pathology, Neuroglia, Deep Learning, Nervous System Diseases
- Abstract
Astrocytes, a type of glial cell, significantly influence neuronal function, with variations in morphology and density linked to neurological disorders. Traditional methods for their accurate detection and density measurement are laborious and unsuited for large-scale operations. We introduce a dataset from human brain tissues stained with aldehyde dehydrogenase 1 family member L1 (ALDH1L1) and glial fibrillary acidic protein (GFAP). The digital whole slide images of these tissues were partitioned into 8730 patches of 500 × 500 pixels, comprising 2323 ALDH1L1 and 4714 GFAP patches at a pixel size of 0.5019/pixel, furthermore 1382 ADHD1L1 and 311 GFAP patches at 0.3557/pixel. Sourced from 16 slides and 8 patients our dataset promotes the development of tools for glial cell detection and quantification, offering insights into their density distribution in various brain areas, thereby broadening neuropathological study horizons. These samples hold value for automating detection methods, including deep learning. Derived from human samples, our dataset provides a platform for exploring astrocyte functionality, potentially guiding new diagnostic and treatment strategies for neurological disorders., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
123. Systematic detection of co-infection and intra-host recombination in more than 2 million global SARS-CoV-2 samples.
- Author
-
Pipek OA, Medgyes-Horváth A, Stéger J, Papp K, Visontai D, Koopmans M, Nieuwenhuijse D, Oude Munnink BB, and Csabai I
- Subjects
- Humans, SARS-CoV-2 genetics, Mutation, Recombination, Genetic, Coinfection, COVID-19
- Abstract
Systematic monitoring of SARS-CoV-2 co-infections between different lineages and assessing the risk of intra-host recombinant emergence are crucial for forecasting viral evolution. Here we present a comprehensive analysis of more than 2 million SARS-CoV-2 raw read datasets submitted to the European COVID-19 Data Portal to identify co-infections and intra-host recombination. Co-infection was observed in 0.35% of the investigated cases. Two independent procedures were implemented to detect intra-host recombination. We show that sensitivity is predominantly determined by the density of lineage-defining mutations along the genome, thus we used an expanded list of mutually exclusive defining mutations of specific variant combinations to increase statistical power. We call attention to multiple challenges rendering recombinant detection difficult and provide guidelines for the reduction of false positives arising from chimeric sequences produced during PCR amplification. Additionally, we identify three recombination hotspots of Delta - Omicron BA.1 intra-host recombinants., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
124. Biologically informed deep learning for explainable epigenetic clocks.
- Author
-
Prosz A, Pipek O, Börcsök J, Palla G, Szallasi Z, Spisak S, and Csabai I
- Subjects
- Algorithms, DNA Methylation, Epigenesis, Genetic, Deep Learning
- Abstract
Ageing is often characterised by progressive accumulation of damage, and it is one of the most important risk factors for chronic disease development. Epigenetic mechanisms including DNA methylation could functionally contribute to organismal aging, however the key functions and biological processes may govern ageing are still not understood. Although age predictors called epigenetic clocks can accurately estimate the biological age of an individual based on cellular DNA methylation, their models have limited ability to explain the prediction algorithm behind and underlying key biological processes controlling ageing. Here we present XAI-AGE, a biologically informed, explainable deep neural network model for accurate biological age prediction across multiple tissue types. We show that XAI-AGE outperforms the first-generation age predictors and achieves similar results to deep learning-based models, while opening up the possibility to infer biologically meaningful insights of the activity of pathways and other abstract biological processes directly from the model., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
125. Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma.
- Author
-
Prosz A, Duan H, Tisza V, Sahgal P, Topka S, Klus GT, Börcsök J, Sztupinszki Z, Hanlon T, Diossy M, Vizkeleti L, Stormoen DR, Csabai I, Pappot H, Vijai J, Offit K, Ried T, Sethi N, Mouw KW, Spisak S, Pathania S, and Szallasi Z
- Subjects
- Humans, DNA Repair, DNA Damage, Ultraviolet Rays, Xeroderma Pigmentosum Group D Protein genetics, Carcinoma, Renal Cell drug therapy, Carcinoma, Renal Cell genetics, Sesquiterpenes, Kidney Neoplasms drug therapy, Kidney Neoplasms genetics
- Abstract
Due to a demonstrated lack of DNA repair deficiencies, clear cell renal cell carcinoma (ccRCC) has not benefitted from targeted synthetic lethality-based therapies. We investigated whether nucleotide excision repair (NER) deficiency is present in an identifiable subset of ccRCC cases that would render those tumors sensitive to therapy targeting this specific DNA repair pathway aberration. We used functional assays that detect UV-induced 6-4 pyrimidine-pyrimidone photoproducts to quantify NER deficiency in ccRCC cell lines. We also measured sensitivity to irofulven, an experimental cancer therapeutic agent that specifically targets cells with inactivated transcription-coupled nucleotide excision repair (TC-NER). In order to detect NER deficiency in clinical biopsies, we assessed whole exome sequencing data for the presence of an NER deficiency associated mutational signature previously identified in ERCC2 mutant bladder cancer. Functional assays showed NER deficiency in ccRCC cells. Some cell lines showed irofulven sensitivity at a concentration that is well tolerated by patients. Prostaglandin reductase 1 (PTGR1), which activates irofulven, was also associated with this sensitivity. Next generation sequencing data of the cell lines showed NER deficiency-associated mutational signatures. A significant subset of ccRCC patients had the same signature and high PTGR1 expression. ccRCC cell line-based analysis showed that NER deficiency is likely present in this cancer type. Approximately 10% of ccRCC patients in the TCGA cohort showed mutational signatures consistent with ERCC2 inactivation associated NER deficiency and also substantial levels of PTGR1 expression. These patients may be responsive to irofulven, a previously abandoned anticancer agent that has minimal activity in NER-proficient cells., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
126. Bacterial colony size growth estimation by deep learning.
- Author
-
Nagy SÁ, Makrai L, Csabai I, Tőzsér D, Szita G, and Solymosi N
- Subjects
- Rifampin pharmacology, Neural Networks, Computer, Deep Learning
- Abstract
The bacterial growth rate is important for pathogenicity and food safety. Therefore, the study of bacterial growth rate over time can provide important data from a medical and veterinary point of view. We trained convolutional neural networks (CNNs) on manually annotated solid medium cultures to detect bacterial colonies as accurately as possible. Predictions of bacterial colony size and growth rate were estimated from image sequences of independent Staphylococcus aureus cultures using trained CNNs. A simple linear model for control cultures with less than 150 colonies estimated that the mean growth rate was 60.3 [Formula: see text] for the first 24 h. Analyzing with a mixed effect model that also takes into account the effect of culture, smaller values of change in colony size were obtained (control: 51.0 [Formula: see text], rifampicin pretreated: 36.5[Formula: see text]). An increase in the number of neighboring colonies clearly reduces the colony growth rate in the control group but less typically in the rifampicin-pretreated group. Based on our results, CNN-based bacterial colony detection and the subsequent analysis of bacterial colony growth dynamics might become an accurate and efficient tool for bacteriological work and research., (© 2023. BioMed Central Ltd., part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
127. Author Correction: A biallelic multiple nucleotide length polymorphism explains functional causality at 5p15.33 prostate cancer risk locus.
- Author
-
Spisak S, Tisza V, Nuzzo PV, Seo JH, Pataki B, Ribli D, Sztupinszki Z, Bell C, Rohanizadegan M, Stillman DR, Alaiwi SA, Bartels AH, Papp M, Shetty A, Abbasi F, Lin X, Lawrenson K, Gayther SA, Pomerantz M, Baca S, Solymosi N, Csabai I, Szallasi Z, Gusev A, and Freedman ML
- Published
- 2023
- Full Text
- View/download PDF
128. A biallelic multiple nucleotide length polymorphism explains functional causality at 5p15.33 prostate cancer risk locus.
- Author
-
Spisak S, Tisza V, Nuzzo PV, Seo JH, Pataki B, Ribli D, Sztupinszki Z, Bell C, Rohanizadegan M, Stillman DR, Alaiwi SA, Bartels AH, Papp M, Shetty A, Abbasi F, Lin X, Lawrenson K, Gayther SA, Pomerantz M, Baca S, Solymosi N, Csabai I, Szallasi Z, Gusev A, and Freedman ML
- Subjects
- Humans, Male, Chromatin genetics, Acetylation, Alleles, Nucleotides, Polymorphism, Single Nucleotide, Neoplasms
- Abstract
To date, single-nucleotide polymorphisms (SNPs) have been the most intensively investigated class of polymorphisms in genome wide associations studies (GWAS), however, other classes such as insertion-deletion or multiple nucleotide length polymorphism (MNLPs) may also confer disease risk. Multiple reports have shown that the 5p15.33 prostate cancer risk region is a particularly strong expression quantitative trait locus (eQTL) for Iroquois Homeobox 4 (IRX4) transcripts. Here, we demonstrate using epigenome and genome editing that a biallelic (21 and 47 base pairs (bp)) MNLP is the causal variant regulating IRX4 transcript levels. In LNCaP prostate cancer cells (homozygous for the 21 bp short allele), a single copy knock-in of the 47 bp long allele potently alters the chromatin state, enabling de novo functional binding of the androgen receptor (AR) associated with increased chromatin accessibility, Histone 3 lysine 27 acetylation (H3K27ac), and ~3-fold upregulation of IRX4 expression. We further show that an MNLP is amongst the strongest candidate susceptibility variants at two additional prostate cancer risk loci. We estimated that at least 5% of prostate cancer risk loci could be explained by functional non-SNP causal variants, which may have broader implications for other cancers GWAS. More generally, our results underscore the importance of investigating other classes of inherited variation as causal mediators of human traits., (© 2023. Springer Nature Limited.)
- Published
- 2023
- Full Text
- View/download PDF
129. Annotated dataset for deep-learning-based bacterial colony detection.
- Author
-
Makrai L, Fodróczy B, Nagy SÁ, Czeiszing P, Csabai I, Szita G, and Solymosi N
- Subjects
- Bacteria, Neural Networks, Computer, Artificial Intelligence, Deep Learning
- Abstract
Quantifying bacteria per unit mass or volume is a common task in various fields of microbiology (e.g., infectiology and food hygiene). Most bacteria can be grown on culture media. The unicellular bacteria reproduce by dividing into two cells, which increases the number of bacteria in the population. Methodologically, this can be followed by culture procedures, which mostly involve determining the number of bacterial colonies on the solid culture media that are visible to the naked eye. However, it is a time-consuming and laborious professional activity. Addressing the automation of colony counting by convolutional neural networks in our work, we have cultured 24 bacteria species of veterinary importance with different concentrations on solid media. A total of 56,865 colonies were annotated manually by bounding boxes on the 369 digital images of bacterial cultures. The published dataset will help developments that use artificial intelligence to automate the counting of bacterial colonies., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
130. Liquid biopsy-based monitoring of residual disease in multiple myeloma by analysis of the rearranged immunoglobulin genes-A feasibility study.
- Author
-
Marx A, Osváth M, Szikora B, Pipek O, Csabai I, Nagy Á, Bödör C, Matula Z, Nagy G, Bors A, Uher F, Mikala G, Vályi-Nagy I, and Kacskovics I
- Subjects
- Humans, Feasibility Studies, Reproducibility of Results, Translocation, Genetic, Immunoglobulin Heavy Chains genetics, Neoplasm, Residual diagnosis, Neoplasm, Residual genetics, Neoplasm, Residual pathology, Genes, Immunoglobulin, Multiple Myeloma diagnosis, Multiple Myeloma genetics
- Abstract
The need for sensitive monitoring of minimal/measurable residual disease (MRD) in multiple myeloma emerged as novel therapies led to deeper responses. Moreover, the potential benefits of blood-based analyses, the so-called liquid biopsy is prompting more and more studies to assess its feasibility. Considering these recent demands, we aimed to optimize a highly sensitive molecular system based on the rearranged immunoglobulin (Ig) genes to monitor MRD from peripheral blood. We analyzed a small group of myeloma patients with the high-risk t(4;14) translocation, using next-generation sequencing of Ig genes and droplet digital PCR of patient-specific Ig heavy chain (IgH) sequences. Moreover, well established monitoring methods such as multiparametric flow cytometry and RT-qPCR of the fusion transcript IgH::MMSET (IgH and multiple myeloma SET domain-containing protein) were utilized to evaluate the feasibility of these novel molecular tools. Serum measurements of M-protein and free light chains together with the clinical assessment by the treating physician served as routine clinical data. We found significant correlation between our molecular data and clinical parameters, using Spearman correlations. While the comparisons of the Ig-based methods and the other monitoring methods (flow cytometry, qPCR) were not statistically evaluable, we found common trends in their target detection. Regarding longitudinal disease monitoring, the applied methods yielded complementary information thus increasing the reliability of MRD evaluation. We also detected indications of early relapse before clinical signs, although this implication needs further verification in a larger patient cohort., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2023 Marx et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2023
- Full Text
- View/download PDF
131. Genomic Landscape of Normal and Breast Cancer Tissues in a Hungarian Pilot Cohort.
- Author
-
Pipek O, Alpár D, Rusz O, Bödör C, Udvarnoki Z, Medgyes-Horváth A, Csabai I, Szállási Z, Madaras L, Kahán Z, Cserni G, Kővári B, Kulka J, and Tőkés AM
- Subjects
- Humans, Female, Hungary, DNA Copy Number Variations, Genetic Predisposition to Disease, Mutation, Germ-Line Mutation, Genomics, Breast Neoplasms pathology
- Abstract
A limited number of studies have focused on the mutational landscape of breast cancer in different ethnic populations within Europe and compared the data with other ethnic groups and databases. We performed whole-genome sequencing of 63 samples from 29 Hungarian breast cancer patients. We validated a subset of the identified variants at the DNA level using the Illumina TruSight Oncology (TSO) 500 assay. Canonical breast-cancer-associated genes with pathogenic germline mutations were CHEK2 and ATM . Nearly all the observed germline mutations were as frequent in the Hungarian breast cancer cohort as in independent European populations. The majority of the detected somatic short variants were single-nucleotide polymorphisms (SNPs), and only 8% and 6% of them were deletions or insertions, respectively. The genes most frequently affected by somatic mutations were KMT2C (31%), MUC4 (34%), PIK3CA (18%), and TP53 (34%). Copy number alterations were most common in the NBN , RAD51C , BRIP1 , and CDH1 genes. For many samples, the somatic mutational landscape was dominated by mutational processes associated with homologous recombination deficiency (HRD). Our study, as the first breast tumor/normal sequencing study in Hungary, revealed several aspects of the significantly mutated genes and mutational signatures, and some of the copy number variations and somatic fusion events. Multiple signs of HRD were detected, highlighting the value of the comprehensive genomic characterization of breast cancer patient populations.
- Published
- 2023
- Full Text
- View/download PDF
132. Automated prediction of COVID-19 severity upon admission by chest X-ray images and clinical metadata aiming at accuracy and explainability.
- Author
-
Olar A, Biricz A, Bedőházi Z, Sulyok B, Pollner P, and Csabai I
- Subjects
- Humans, Metadata, X-Rays, Hospitalization, Artificial Intelligence, COVID-19 diagnostic imaging
- Abstract
In the past few years COVID-19 posed a huge threat to healthcare systems around the world. One of the first waves of the pandemic hit Northern Italy severely resulting in high casualties and in the near breakdown of primary care. Due to these facts, the Covid CXR Hackathon-Artificial Intelligence for Covid-19 prognosis: aiming at accuracy and explainability challenge had been launched at the beginning of February 2022, releasing a new imaging dataset with additional clinical metadata for each accompanying chest X-ray (CXR). In this article we summarize our techniques at correctly diagnosing chest X-ray images collected upon admission for severity of COVID-19 outcome. In addition to X-ray imagery, clinical metadata was provided and the challenge also aimed at creating an explainable model. We created a best-performing, as well as, an explainable model that makes an effort to map clinical metadata to image features whilst predicting the prognosis. We also did many ablation studies in order to identify crucial parts of the models and the predictive power of each feature in the datasets. We conclude that CXRs at admission do not help the predicting power of the metadata significantly by itself and contain mostly information that is also mutually present in the blood samples and other clinical factors collected at admission., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
133. SARS-CoV-2 receptor-binding domain deep mutational AlphaFold2 structures.
- Author
-
Kilim O, Mentes A, Pál B, Csabai I, and Gellért Á
- Subjects
- Humans, Computer Simulation, Furylfuramide, Mutation, COVID-19, SARS-CoV-2 genetics
- Abstract
Leveraging recent advances in computational modeling of proteins with AlphaFold2 (AF2) we provide a complete curated data set of all single mutations from each of the 7 main SARS-CoV-2 lineages spike protein receptor binding domain (RBD) resulting in 3819X7 = 26733 PDB structures. We visualize the generated structures and show that AF2 pLDDT values are correlated with state-of-the-art disorder approximations, implying some internal protein dynamics are also captured by the model. Joint increasing mutational coverage of both structural and phenotype data coupled with advances in machine learning can be leveraged to accelerate virology research, specifically future variant prediction. We hope this data release can offer assistance into further understanding of the local and global mutational landscape of SARS-CoV-2 as well as provide insight into the biological understanding that 3D structure acts as a bridge between protein genotype and phenotype., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
134. Patterns of Somatic Variants in Colorectal Adenoma and Carcinoma Tissue and Matched Plasma Samples from the Hungarian Oncogenome Program.
- Author
-
Kalmár A, Galamb O, Szabó G, Pipek O, Medgyes-Horváth A, Barták BK, Nagy ZB, Szigeti KA, Zsigrai S, Csabai I, Igaz P, Molnár B, and Takács I
- Abstract
Analysis of circulating cell-free DNA (cfDNA) of colorectal adenoma (AD) and cancer (CRC) patients provides a minimally invasive approach that is able to explore genetic alterations. It is unknown whether there are specific genetic variants that could explain the high prevalence of CRC in Hungary. Whole-exome sequencing (WES) was performed on colon tissues (27 AD, 51 CRC) and matched cfDNAs (17 AD, 33 CRC); furthermore, targeted panel sequencing was performed on a subset of cfDNA samples. The most frequently mutated genes were APC , KRAS , and FBN3 in AD, while APC , TP53 , TTN , and KRAS were the most frequently mutated in CRC tissue. Variants in KRAS codons 12 (AD: 8/27, CRC: 11/51 (0.216)) and 13 (CRC: 3/51 (0.06)) were the most frequent in our sample set, with G12V (5/27) dominance in ADs and G12D (5/51 (0.098)) in CRCs. In terms of the cfDNA WES results, tumor somatic variants were found in 6/33 of CRC cases. Panel sequencing revealed somatic variants in 8 out of the 12 enrolled patients, identifying 12/20 tumor somatic variants falling on its targeted regions, while WES recovered only 20% in the respective regions in cfDNA of the same patients. In liquid biopsy analyses, WES is less efficient compared to the targeted panel sequencing with a higher coverage depth that can hold a relevant clinical potential to be applied in everyday practice in the future.
- Published
- 2023
- Full Text
- View/download PDF
135. Impact Evaluation of Score Classes and Annotation Regions in Deep Learning-Based Dairy Cow Body Condition Prediction.
- Author
-
Nagy SÁ, Kilim O, Csabai I, Gábor G, and Solymosi N
- Abstract
Body condition scoring is a simple method to estimate the energy supply of dairy cattle. Our study aims to investigate the accuracy with which supervised machine learning, specifically a deep convolutional neural network (CNN), can be used to retrieve body condition score (BCS) classes estimated by an expert. We recorded images of animals' rumps in three large-scale farms using a simple action camera. The images were annotated with classes and three different-sized bounding boxes by an expert. A CNN pretrained model was fine-tuned on 12 and 3 BCS classes. Training in 12 classes with a 0 error range, the Cohen's kappa value yielded minimal agreement between the model predictions and ground truth. Allowing an error range of 0.25, we obtained minimum or weak agreement. With an error range of 0.5, we had strong or almost perfect agreement. The kappa values for the approach trained on three classes show that we can classify all animals into BCS categories with at least moderate agreement. Furthermore, CNNs trained on 3 BCS classes showed a remarkably higher proportion of strong agreement than those trained in 12 classes. The prediction precision when training with various annotation region sizes showed no meaningful differences. The weights of our trained CNNs are freely available, supporting similar works.
- Published
- 2023
- Full Text
- View/download PDF
136. Machine Learning-Based Characterization of the Nanostructure in a Combinatorial Co-Cr-Fe-Ni Compositionally Complex Alloy Film.
- Author
-
Nagy P, Kaszás B, Csabai I, Hegedűs Z, Michler J, Pethö L, and Gubicza J
- Abstract
A novel artificial intelligence-assisted evaluation of the X-ray diffraction (XRD) peak profiles was elaborated for the characterization of the nanocrystallite microstructure in a combinatorial Co-Cr-Fe-Ni compositionally complex alloy (CCA) film. The layer was produced by a multiple beam sputtering physical vapor deposition (PVD) technique on a Si single crystal substrate with the diameter of about 10 cm. This new processing technique is able to produce combinatorial CCA films where the elemental concentrations vary in a wide range on the disk surface. The most important benefit of the combinatorial sample is that it can be used for the study of the correlation between the chemical composition and the microstructure on a single specimen. The microstructure can be characterized quickly in many points on the disk surface using synchrotron XRD. However, the evaluation of the diffraction patterns for the crystallite size and the density of lattice defects (e.g., dislocations and twin faults) using X-ray line profile analysis (XLPA) is not possible in a reasonable amount of time due to the large number (hundreds) of XRD patterns. In the present study, a machine learning-based X-ray line profile analysis (ML-XLPA) was developed and tested on the combinatorial Co-Cr-Fe-Ni film. The new method is able to produce maps of the characteristic parameters of the nanostructure (crystallite size, defect densities) on the disk surface very quickly. Since the novel technique was developed and tested only for face-centered cubic (FCC) structures, additional work is required for the extension of its applicability to other materials. Nevertheless, to the knowledge of the authors, this is the first ML-XLPA evaluation method in the literature, which can pave the way for further development of this methodology.
- Published
- 2022
- Full Text
- View/download PDF
137. Physical imaging parameter variation drives domain shift.
- Author
-
Kilim O, Olar A, Joó T, Palicz T, Pollner P, and Csabai I
- Subjects
- Humans, Algorithms, Diagnostic Imaging
- Abstract
Statistical learning algorithms strongly rely on an oversimplified assumption for optimal performance, that is, source (training) and target (testing) data are independent and identically distributed. Variation in human tissue, physician labeling and physical imaging parameters (PIPs) in the generative process, yield medical image datasets with statistics that render this central assumption false. When deploying models, new examples are often out of distribution with respect to training data, thus, training robust dependable and predictive models is still a challenge in medical imaging with significant accuracy drops common for deployed models. This statistical variation between training and testing data is referred to as domain shift (DS).To the best of our knowledge we provide the first empirical evidence that variation in PIPs between test and train medical image datasets is a significant driver of DS and model generalization error is correlated with this variance. We show significant covariate shift occurs due to a selection bias in sampling from a small area of PIP space for both inter and intra-hospital regimes. In order to show this, we control for population shift, prevalence shift, data selection biases and annotation biases to investigate the sole effect of the physical generation process on model generalization for a proxy task of age group estimation on a combined 44 k image mammogram dataset collected from five hospitals.We hypothesize that training data should be sampled evenly from PIP space to produce the most robust models and hope this study provides motivation to retain medical image generation metadata that is almost always discarded or redacted in open source datasets. This metadata measured with standard international units can provide a universal regularizing anchor between distributions generated across the world for all current and future imaging modalities., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
138. Identification of mutations in SARS-CoV-2 PCR primer regions.
- Author
-
Mentes A, Papp K, Visontai D, Stéger J, Csabai I, Medgyes-Horváth A, and Pipek OA
- Subjects
- Humans, COVID-19 Testing, Polymerase Chain Reaction, Mutation, Sensitivity and Specificity, SARS-CoV-2 genetics, COVID-19 diagnosis, COVID-19 genetics
- Abstract
Due to the constantly increasing number of mutations in the SARS-CoV-2 genome, concerns have emerged over the possibility of decreased diagnostic accuracy of reverse transcription-polymerase chain reaction (RT-PCR), the gold standard diagnostic test for SARS-CoV-2. We propose an analysis pipeline to discover genomic variations overlapping the target regions of commonly used PCR primer sets. We provide the list of these mutations in a publicly available format based on a dataset of more than 1.2 million SARS-CoV-2 samples. Our approach distinguishes among mutations possibly having a damaging impact on PCR efficiency and ones anticipated to be neutral in this sense. Samples are categorized as "prone to misclassification" vs. "likely to be correctly detected" by a given PCR primer set based on the estimated effect of mutations present. Samples susceptible to misclassification are generally present at a daily rate of 2% or lower, although particular primer sets seem to have compromised performance when detecting Omicron samples. As different variant strains may temporarily gain dominance in the worldwide SARS-CoV-2 viral population, the efficiency of a particular PCR primer set may change over time, therefore constant monitoring of variations in primer target regions is highly recommended., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
139. Predicting Patient-Level 3-Level Version of EQ-5D Index Scores From a Large International Database Using Machine Learning and Regression Methods.
- Author
-
Zrubka Z, Csabai I, Hermann Z, Golicki D, Prevolnik-Rupel V, Ogorevc M, Gulácsi L, and Péntek M
- Subjects
- Health Status, Humans, Least-Squares Analysis, Machine Learning, Surveys and Questionnaires, Artificial Intelligence, Quality of Life
- Abstract
Objectives: This study aimed to evaluate the performance of machine learning and regression methods in the prediction of 3-level version of EQ-5D (EQ-5D-3L) index scores from a large diverse data set., Methods: A total of 30 studies from 3 countries were combined. Predictions were performed via eXtreme Gradient Boosting classification (XGBC), eXtreme Gradient Boosting regression (XGBR) and ordinary least squares (OLS) regression using 10-fold cross-validation and 80%/20% partition for training and testing. We evaluated 6 prediction scenarios using 3 samples (general population, patients, total) and 2 predictor sets: demographic and disease-related variables with/without patient-reported outcomes. Model performance was evaluated by mean absolute error and percent of predictions within clinically irrelevant error range and within correct health severity group (EQ-5D-3L index <0.45, 0.45-0.926, >0.926)., Results: The data set involved 26 318 individuals (clinical settings n = 6214, general population n = 20 104) and 26 predictor variables plus diagnoses. Using all predictors and the total sample, mean absolute error values were 0.153, 0.126, and 0.131, percent of predictions within clinically irrelevant error range were 47.6%, 39.5%, and 37.4%, and within the correct health severity group were 56.3%, 64.9%, and 63.3% by XGBC, XGBR, and OLS, respectively. The performance of models depended on the applied evaluation criteria, the target population, the included predictors, and the EQ-5D-3L index score range., Conclusions: Regression models (XGBR and OLS) outperformed XGBC, yet prediction errors were outside the clinically irrelevant error range for most respondents. Our results highlight the importance of systematic patient-reported outcome (EQ-5D) data collection. Dialogs between artificial intelligence and outcomes research experts are encouraged to enhance the value of accumulating data in health systems., (Copyright © 2022. Published by Elsevier Inc.)
- Published
- 2022
- Full Text
- View/download PDF
140. HunCRC: annotated pathological slides to enhance deep learning applications in colorectal cancer screening.
- Author
-
Pataki BÁ, Olar A, Ribli D, Pesti A, Kontsek E, Gyöngyösi B, Bilecz Á, Kovács T, Kovács KA, Kramer Z, Kiss A, Szócska M, Pollner P, and Csabai I
- Subjects
- Diagnosis, Computer-Assisted, Early Detection of Cancer, Humans, Neural Networks, Computer, Colorectal Neoplasms diagnosis, Deep Learning
- Abstract
Histopathology is the gold standard method for staging and grading human tumors and provides critical information for the oncoteam's decision making. Highly-trained pathologists are needed for careful microscopic analysis of the slides produced from tissue taken from biopsy. This is a time-consuming process. A reliable decision support system would assist healthcare systems that often suffer from a shortage of pathologists. Recent advances in digital pathology allow for high-resolution digitalization of pathological slides. Digital slide scanners combined with modern computer vision models, such as convolutional neural networks, can help pathologists in their everyday work, resulting in shortened diagnosis times. In this study, 200 digital whole-slide images are published which were collected via hematoxylin-eosin stained colorectal biopsy. Alongside the whole-slide images, detailed region level annotations are also provided for ten relevant pathological classes. The 200 digital slides, after pre-processing, resulted in 101,389 patches. A single patch is a 512 × 512 pixel image, covering 248 × 248 μm
2 tissue area. Versions at higher resolution are available as well. Hopefully, HunCRC, this widely accessible dataset will aid future colorectal cancer computer-aided diagnosis and research., (© 2022. The Author(s).)- Published
- 2022
- Full Text
- View/download PDF
141. Folic Acid Treatment Directly Influences the Genetic and Epigenetic Regulation along with the Associated Cellular Maintenance Processes of HT-29 and SW480 Colorectal Cancer Cell Lines.
- Author
-
Zsigrai S, Kalmár A, Barták BK, Nagy ZB, Szigeti KA, Valcz G, Kothalawala W, Dankó T, Sebestyén A, Barna G, Pipek O, Csabai I, Tulassay Z, Igaz P, Takács I, and Molnár B
- Abstract
Folic acid (FA) is a synthetic form of vitamin B9, generally used as a nutritional supplement and an adjunctive medication in cancer therapy. FA is involved in genetic and epigenetic regulation; therefore, it has a dual modulatory role in established neoplasms. We aimed to investigate the effect of short-term (72 h) FA supplementation on colorectal cancer; hence, HT-29 and SW480 cells were exposed to different FA concentrations (0, 100, 10,000 ng/mL). HT-29 cell proliferation and viability levels elevated after 100 ng/mL but decreased for 10,000 ng/mL FA. Additionally, a significant ( p ≤ 0.05) improvement of genomic stability was detected in HT-29 cells with micronucleus scoring and comet assay. Conversely, the FA treatment did not alter these parameters in SW480 samples. RRBS results highlighted that DNA methylation changes were bidirectional in both cells, mainly affecting carcinogenesis-related pathways. Based on the microarray analysis, promoter methylation status was in accordance with FA-induced expression alterations of 27 genes. Our study demonstrates that the FA effect was highly dependent on the cell type, which can be attributed to the distinct molecular background and the different expression of proliferation- and DNA-repair-associated genes ( YWHAZ , HES1 , STAT3 , CCL2 ). Moreover, new aspects of FA-regulated DNA methylation and consecutive gene expression were revealed.
- Published
- 2022
- Full Text
- View/download PDF
142. Transcriptomic signatures of tumors undergoing T cell attack.
- Author
-
Gokuldass A, Schina A, Lauss M, Harbst K, Chamberlain CA, Draghi A, Westergaard MCW, Nielsen M, Papp K, Sztupinszki Z, Csabai I, Svane IM, Szallasi Z, Jönsson G, and Donia M
- Subjects
- Cell Line, Tumor, Coculture Techniques, Computational Biology methods, DNA Contamination, Gene Expression Profiling methods, Gene Expression Profiling standards, Gene Expression Regulation, Neoplastic drug effects, Humans, Immune Checkpoint Inhibitors, Molecular Targeted Therapy, Neoplasms drug therapy, Neoplasms metabolism, Neoplasms pathology, Organ Specificity, ROC Curve, Tumor Cells, Cultured, Biomarkers, Tumor, Lymphocytes, Tumor-Infiltrating immunology, Lymphocytes, Tumor-Infiltrating metabolism, Neoplasms etiology, Transcriptome, Tumor Microenvironment genetics, Tumor Microenvironment immunology
- Abstract
Background: Studying tumor cell-T cell interactions in the tumor microenvironment (TME) can elucidate tumor immune escape mechanisms and help predict responses to cancer immunotherapy., Methods: We selected 14 pairs of highly tumor-reactive tumor-infiltrating lymphocytes (TILs) and autologous short-term cultured cell lines, covering four distinct tumor types, and co-cultured TILs and tumors at sub-lethal ratios in vitro to mimic the interactions occurring in the TME. We extracted gene signatures associated with a tumor-directed T cell attack based on transcriptomic data of tumor cells., Results: An autologous T cell attack induced pronounced transcriptomic changes in the attacked tumor cells, partially independent of IFN-γ signaling. Transcriptomic changes were mostly independent of the tumor histological type and allowed identifying common gene expression changes, including a shared gene set of 55 transcripts influenced by T cell recognition (Tumors undergoing T cell attack, or TuTack, focused gene set). TuTack scores, calculated from tumor biopsies, predicted the clinical outcome after anti-PD-1/anti-PD-L1 therapy in multiple tumor histologies. Notably, the TuTack scores did not correlate to the tumor mutational burden, indicating that these two biomarkers measure distinct biological phenomena., Conclusions: The TuTack scores measure the effects on tumor cells of an anti-tumor immune response and represent a comprehensive method to identify immunologically responsive tumors. Our findings suggest that TuTack may allow patient selection in immunotherapy clinical trials and warrant its application in multimodal biomarker strategies., (© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
143. Strand Orientation Bias Detector to determine the probability of FFPE sequencing artifacts.
- Author
-
Diossy M, Sztupinszki Z, Krzystanek M, Borcsok J, Eklund AC, Csabai I, Pedersen AG, and Szallasi Z
- Subjects
- Algorithms, DNA, Neoplasm, Databases, Genetic, High-Throughput Nucleotide Sequencing methods, Humans, Mutation, Neoplasms diagnosis, Neoplasms genetics, Reproducibility of Results, Sequence Analysis, DNA methods, Artifacts, Cytological Techniques standards, High-Throughput Nucleotide Sequencing standards, Models, Statistical, Sequence Analysis, DNA standards, Templates, Genetic
- Abstract
Formalin-fixed paraffin-embedded tissue, the most common tissue specimen stored in clinical practice, presents challenges in the analysis due to formalin-induced artifacts. Here, we present Strand Orientation Bias Detector (SOBDetector), a flexible computational platform compatible with all the common somatic SNV-calling pipelines, designed to assess the probability whether a given detected mutation is an artifact. The underlying predictor mechanism is based on the posterior distribution of a Bayesian logistic regression model trained on The Cancer Genome Atlas whole exomes. SOBDetector is a freely available cross-platform program, implemented in Java 1.8., (© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.)
- Published
- 2021
- Full Text
- View/download PDF
144. Detection of antimicrobial resistance genes in urban air.
- Author
-
Becsei Á, Solymosi N, Csabai I, and Magyar D
- Subjects
- Cities, Metagenome, Sensitivity and Specificity, Air Microbiology, Bacteria genetics, Drug Resistance, Bacterial genetics, Genes, Bacterial, Microbiota
- Abstract
To understand antibiotic resistance in pathogenic bacteria, we need to monitor environmental microbes as reservoirs of antimicrobial resistance genes (ARGs). These bacteria are present in the air and can be investigated with the whole metagenome shotgun sequencing approach. This study aimed to investigate the feasibility of a method for metagenomic analysis of microbial composition and ARGs in the outdoor air. Air samples were collected with a Harvard impactor in the PM
10 range at 50 m from a hospital in Budapest. From the DNA yielded from samples of PM10 fraction single-end reads were generated with an Ion Torrent sequencer. During the metagenomic analysis, reads were classified taxonomically. The core bacteriome was defined. Reads were assembled to contigs and the ARG content was analyzed. The dominant genera in the core bacteriome were Bacillus, Acinetobacter, Leclercia and Paenibacillus. Among the identified ARGs best hits were vanRA, Bla1, mphL, Escherichia coli EF-Tu mutants conferring resistance to pulvomycin; BcI, FosB, and mphM. Despite the low DNA content of the samples of PM10 fraction, the number of detected airborne ARGs was surprisingly high., (© 2021 The Authors. MicrobiologyOpen published by John Wiley & Sons Ltd.)- Published
- 2021
- Full Text
- View/download PDF
145. Mobile Antimicrobial Resistance Genes in Probiotics.
- Author
-
Tóth AG, Csabai I, Judge MF, Maróti G, Becsei Á, Spisák S, and Solymosi N
- Abstract
Even though people worldwide tend to consume probiotic products for their beneficial health effects on a daily basis, recently, concerns were outlined regarding the uptake and potential intestinal colonisation of the bacteria that they carry. These bacteria are capable of executing horizontal gene transfer (HGT) which facilitates the movement of various genes, including antimicrobial resistance genes (ARGs), among the donor and recipient bacterial populations. Within our study, 47 shotgun sequencing datasets deriving from various probiotic samples (isolated strains and metagenomes) were bioinformatically analysed. We detected more than 70 ARGs, out of which rpoB mutants conferring resistance to rifampicin, tet(W/N/W) and potentially extended-spectrum beta-lactamase (ESBL) coding TEM-116 were the most common. Numerous ARGs were associated with integrated mobile genetic elements, plasmids or phages promoting the HGT. Our findings raise clinical and public health concerns as the consumption of probiotic products may lead to the transfer of ARGs to human gut bacteria.
- Published
- 2021
- Full Text
- View/download PDF
146. Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor-Antigens.
- Author
-
Draghi A, Chamberlain CA, Khan S, Papp K, Lauss M, Soraggi S, Radic HD, Presti M, Harbst K, Gokuldass A, Kverneland A, Nielsen M, Westergaard MCW, Andersen MH, Csabai I, Jönsson G, Szallasi Z, Svane IM, and Donia M
- Subjects
- Antigens, CD analysis, Apyrase analysis, CD4-Positive T-Lymphocytes immunology, CD8-Positive T-Lymphocytes immunology, Datasets as Topic, Flow Cytometry, Humans, Integrin alpha Chains analysis, Interferon-gamma biosynthesis, Interferon-gamma genetics, Lymphocyte Activation genetics, Lymphocytes, Tumor-Infiltrating immunology, Neoplasm Proteins biosynthesis, Neoplasm Proteins genetics, Single-Cell Analysis, Transcriptome, Tumor Microenvironment immunology, Tumor Necrosis Factor-alpha biosynthesis, Tumor Necrosis Factor-alpha genetics, Antigens, Neoplasm immunology, CD4-Positive T-Lymphocytes chemistry, CD8-Positive T-Lymphocytes chemistry, Interferon-gamma analysis, Lymphocytes, Tumor-Infiltrating chemistry, Neoplasm Proteins analysis, Tumor Necrosis Factor Receptor Superfamily, Member 9 analysis, Tumor Necrosis Factor-alpha analysis
- Abstract
Detecting the entire repertoire of tumor-specific reactive tumor-infiltrating lymphocytes (TILs) is essential for investigating their immunological functions in the tumor microenvironment. Current in vitro assays identifying tumor-specific functional activation measure the upregulation of surface molecules, de novo production of antitumor cytokines, or mobilization of cytotoxic granules following recognition of tumor-antigens, yet there is no widely adopted standard method. Here we established an enhanced, yet simple, method for identifying simultaneously CD8
+ and CD4+ tumor-specific reactive TILs in vitro , using a combination of widely known and available flow cytometry assays. By combining the detection of intracellular CD137 and de novo production of TNF and IFNγ after recognition of naturally-presented tumor antigens, we demonstrate that a larger fraction of tumor-specific and reactive CD8+ TILs can be detected in vitro compared to commonly used assays. This assay revealed multiple polyfunctionality-based clusters of both CD4+ and CD8+ tumor-specific reactive TILs. In situ , the combined detection of TNFRSF9 , TNF , and IFNG identified most of the tumor-specific reactive TIL repertoire. In conclusion, we describe a straightforward method for efficient identification of the tumor-specific reactive TIL repertoire in vitro , which can be rapidly adopted in most cancer immunology laboratories., Competing Interests: MD has received honoraria for lectures from Roche and Novartis (past two years). IMS has received honoraria for consultancies and lectures from Novartis, Roche, Merck, and Bristol-Myers Squibb; a restricted research grant from Novartis; and financial support for attending symposia from Bristol-Myers Squibb, Merck, Novartis, Pfizer, and Roche. HDR is currently an employee at Novo Nordisk. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Draghi, Chamberlain, Khan, Papp, Lauss, Soraggi, Radic, Presti, Harbst, Gokuldass, Kverneland, Nielsen, Westergaard, Andersen, Csabai, Jönsson, Szallasi, Svane and Donia.)- Published
- 2021
- Full Text
- View/download PDF
147. Hierarchy and control of ageing-related methylation networks.
- Author
-
Palla G, Pollner P, Börcsök J, Major A, Molnár B, and Csabai I
- Subjects
- CpG Islands, Humans, Aging genetics, DNA Methylation
- Abstract
DNA methylation provides one of the most widely studied biomarkers of ageing. Since the methylation of CpG dinucleotides function as switches in cellular mechanisms, it is plausible to assume that by proper adjustment of these switches age may be tuned. Though, adjusting hundreds of CpG methylation levels coherently may never be feasible and changing just a few positions may lead to biologically unstable state. A prominent example of methylation-based age estimators is provided by Horvath's clock, based on 353 CpG dinucleotides, showing a high correlation (not necessarily causation) with chronological age across multiple tissue types. On this small subset of CpG dinucleotides we demonstrate how the adjustment of one methylation level leads to a cascade of changes at other sites. Among the studied subset, we locate the most important CpGs (and related genes) that may have a large influence on the rest of the sub-system. According to our analysis, the structure of this network is way more hierarchical compared to what one would expect based on ensembles of uncorrelated connections. Therefore, only a handful of CpGs is enough to modify the system towards a desired state. When propagation of the change over the network is taken into account, the resulting modification in the predicted age can be significantly larger compared to the effect of isolated CpG perturbations. By adjusting the most influential single CpG site and following the propagation of methylation level changes we can reach up to 5.74 years in virtual age reduction, significantly larger than without taking into account of the network control. Extending our approach to the whole methylation network may identify key nodes that have controller role in the ageing process., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2021
- Full Text
- View/download PDF
148. Detection of Molecular Signatures of Homologous Recombination Deficiency in Bladder Cancer.
- Author
-
Börcsök J, Diossy M, Sztupinszki Z, Prosz A, Tisza V, Spisak S, Rusz O, Stormoen DR, Pappot H, Csabai I, Brunak S, Mouw KW, and Szallasi Z
- Subjects
- Humans, BRCA1 Protein genetics, BRCA2 Protein genetics, Homologous Recombination, Mutation, Urinary Bladder Neoplasms genetics
- Abstract
Purpose: Poly (ADP ribose)-polymerase (PARP) inhibitors are approved for use in breast, ovarian, prostate, and pancreatic cancers, which are the solid tumor types that most frequently have alterations in key homologous recombination (HR) genes, such as BRCA1/2 . However, the frequency of HR deficiency (HRD) in other solid tumor types, including bladder cancer, is less well characterized., Experimental Design: Specific DNA aberration profiles (mutational signatures) are induced by HRD, and the presence of these "genomic scars" can be used to assess the presence or absence of HRD in a given tumor biopsy even in the absence of an observed alteration of an HR gene. Using whole-exome and whole-genome data, we measured various HRD-associated mutational signatures in bladder cancer., Results: We found that a subset of bladder tumors have evidence of HRD. In addition to a small number of tumors with biallelic BRCA1/2 events, approximately 10% of bladder tumors had significant evidence of HRD-associated mutational signatures. Increased levels of HRD signatures were associated with promoter methylation of RBBP8 , which encodes CtIP, a key protein involved in HR., Conclusions: A subset of bladder tumors have genomic features suggestive of HRD and therefore may be more likely to benefit from therapies such as platinum agents and PARP inhibitors that target tumor HRD., (©2021 American Association for Cancer Research.)
- Published
- 2021
- Full Text
- View/download PDF
149. A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures.
- Author
-
Diossy M, Sztupinszki Z, Borcsok J, Krzystanek M, Tisza V, Spisak S, Rusz O, Timar J, Csabai I, Fillinger J, Moldvay J, Pedersen AG, Szuts D, and Szallasi Z
- Abstract
PARP inhibitors are approved for the treatment of solid tumor types that frequently harbor alterations in the key homologous recombination (HR) genes, BRCA1/2. Other tumor types, such as lung cancer, may also be HR deficient, but the frequency of such cases is less well characterized. Specific DNA aberration profiles (mutational signatures) are induced by homologous recombination deficiency (HRD) and their presence can be used to assess the presence or absence of HR deficiency in a given tumor biopsy even in the absence of an observed alteration of an HR gene. We derived various HRD-associated mutational signatures from whole-genome and whole-exome sequencing data in the lung adenocarcinoma and lung squamous carcinoma cases from TCGA, and in a patient of ours with stage IVA lung cancer with exceptionally good response to platinum-based therapy, and in lung cancer cell lines. We found that a subset of the investigated cases, both with and without biallelic loss of BRCA1 or BRCA2, showed robust signs of HR deficiency. The extreme platinum responder case also showed a robust HRD-associated genomic mutational profile. HRD-associated mutational signatures were also associated with PARP inhibitor sensitivity in lung cancer cell lines. Consequently, lung cancer cases with HRD, as identified by diagnostic mutational signatures, may benefit from PARP inhibitor therapy.
- Published
- 2021
- Full Text
- View/download PDF
150. Crowdsourcing assessment of maternal blood multi-omics for predicting gestational age and preterm birth.
- Author
-
Tarca AL, Pataki BÁ, Romero R, Sirota M, Guan Y, Kutum R, Gomez-Lopez N, Done B, Bhatti G, Yu T, Andreoletti G, Chaiworapongsa T, Hassan SS, Hsu CD, Aghaeepour N, Stolovitzky G, Csabai I, and Costello JC
- Subjects
- Adult, Asymptomatic Diseases, Biomarkers blood, Blood Proteins classification, Blood Proteins metabolism, Cell-Free Nucleic Acids blood, Cell-Free Nucleic Acids classification, Crowdsourcing methods, Female, Humans, Infant, Newborn, Longitudinal Studies, Pre-Eclampsia blood, Pre-Eclampsia diagnosis, Pregnancy, Premature Birth blood, Premature Birth diagnosis, Proteomics methods, ROC Curve, Blood Proteins genetics, Cell-Free Nucleic Acids genetics, Gestational Age, Pre-Eclampsia genetics, Premature Birth genetics, Transcriptome
- Abstract
Identification of pregnancies at risk of preterm birth (PTB), the leading cause of newborn deaths, remains challenging given the syndromic nature of the disease. We report a longitudinal multi-omics study coupled with a DREAM challenge to develop predictive models of PTB. The findings indicate that whole-blood gene expression predicts ultrasound-based gestational ages in normal and complicated pregnancies (r = 0.83) and, using data collected before 37 weeks of gestation, also predicts the delivery date in both normal pregnancies (r = 0.86) and those with spontaneous preterm birth (r = 0.75). Based on samples collected before 33 weeks in asymptomatic women, our analysis suggests that expression changes preceding preterm prelabor rupture of the membranes are consistent across time points and cohorts and involve leukocyte-mediated immunity. Models built from plasma proteomic data predict spontaneous preterm delivery with intact membranes with higher accuracy and earlier in pregnancy than transcriptomic models (AUROC = 0.76 versus AUROC = 0.6 at 27-33 weeks of gestation)., Competing Interests: A.L.T., R.R., S.S.H., and T.C. are listed as co-inventors on the US 10,802,030 B2 patent, which involves the prediction of preterm birth using proteomics data. All of the other authors declare no competing interests., (© 2021 The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.